TwoStep Therapeutics announced an oversubscribed $62.5 million Series A led by Insight Partners and Medical Excellence Capital alongside FDA clearance of an IND for its lead peptide-drug conjugate.
- Amount
- $62.5M
- Stage
- Series A
- Announced
- 9 September 2026
- Leads
- Insight Partners, Medical Excellence Capital, M Ventures, Pfizer Ventures
- Checked
- Amount and date checked against the press source